Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) General Information
Description
Worldwide rights, except China, Hong Kong, Taiwan and Macau, to RHB-107, a serine protease inhibitor that works against a range of human trypsins, of a pharmaceutical company based in Ladenburg, Germany.
Contact Information
Corporate Office
- Schriesheimer Straße 101
- 68526 Ladenburg
- Germany
Corporate Office
- Schriesheimer Straße 101
- 68526 Ladenburg
- Germany
Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) FAQs
-
Where is Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) headquartered?
Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) is headquartered in Ladenburg, Germany.
-
What industry is Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) in?
Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau)’s primary industry is Buildings and Property.
-
Is Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) a private or public company?
Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) is a Private company.
-
What is Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau)’s current revenue?
The current revenue for Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) is .
-
Who are Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau)’s investors?
Heidelberg Pharma has invested in Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau).
-
Who acquired Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau)?
Heidelberg Pharma (Worldwide Rights To RHB-107, Except China, Hong Kong, Taiwan & Macau) was acquired by RedHill Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process